Hidenao Sasaki

Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial

Koji Abe, Masashi Aoki, Shoji Tsuji et al. · The Lancet Neurology · 2017 · 925 citations

Life Sciences, Neurology, Neuroscience +11

Identification of the spinocerebellar ataxia type 2 gene using a direct identification of repeat expansion and cloning technique, DIRECT

Kazuhiro Sanpei, Hiroki Takano, S. Igarashi et al. · Nature Genetics · 1996 · 774 citations

Life Sciences, Genetics, Molecular Genetics +17

Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomised, double-blind, placebo-controlled trial

Masahisa Katsuno, Haruhiko Banno, Keisuke Suzuki et al. · The Lancet Neurology · 2010 · 188 citations

Medicine, Neurology, Pharmacotherapy +6

Association of vitamin D receptor gene polymorphism with multiple sclerosis in Japanese

Toshiyuki Fukazawa, Ichiro Yabe, Seiji Kikuchi et al. · Journal of the Neurological Sciences · 1999 · 178 citations

Life Sciences, Genetics, Neurology +12

Safety and efficacy of eculizumab in Guillain-Barré syndrome: a multicentre, double-blind, randomised phase 2 trial

Sonoko Misawa, Satoshi Kuwabara, Yasunori Sato et al. · The Lancet Neurology · 2018 · 161 citations

Medicine, Neurology, Pharmacotherapy +4